NR2F1 and central nervous system cancer: NR2F1-AS1 is known to be related to the activation of the PI3K/AKT pathway in endometrial cancer (Wang et al., 2019), and miR-190a has been shown to promote the activation of the PI3K/AKT pathway in gliomas (Jin et al., 2020).